← Back to Search

Physician Payment Models for Heart Conditions

Phase 3
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient inclusion: discharge diagnosis of heart failure or myocardial infarction.
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will compare two models for physician payment, one in which physicians are paid a fee for each service provided (fee-for-service), and one in which physicians are given a bonus for meeting quality standards (pay-for-performance). The goal is to see if the pay-for-performance model results in better care for patients with heart conditions.

Who is the study for?
This trial is for patients with a discharge diagnosis of heart failure or myocardial infarction. It also includes resident physicians at the University of Virginia who work in Acute Cardiology, Coronary Care Unit, or General Medicine Service and are not part of the study team.Check my eligibility
What is being tested?
The study aims to compare two payment models for doctors: 'pay for performance' versus traditional 'fee for service'. The focus is on whether financial incentives can improve adherence to healthcare standards in treating heart conditions.See study design
What are the potential side effects?
Since this trial involves financial compensation methods rather than medical treatments, there are no direct medical side effects. However, changes in physician behavior could indirectly affect patient care outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I was diagnosed with heart failure or had a heart attack.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
compliance with composite pay for performance measure
Secondary outcome measures
heart failure composite score
myocardial infarction score
readmission rate

Trial Design

2Treatment groups
Active Control
Group I: pay for performanceActive Control1 Intervention
Group II: no pay for performanceActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,993 Total Patients Enrolled
11 Trials studying Heart Failure
1,514 Patients Enrolled for Heart Failure

Media Library

pay for performance Clinical Trial Eligibility Overview. Trial Name: NCT01590290 — Phase 3
Heart Failure Research Study Groups: pay for performance, no pay for performance
Heart Failure Clinical Trial 2023: pay for performance Highlights & Side Effects. Trial Name: NCT01590290 — Phase 3
pay for performance 2023 Treatment Timeline for Medical Study. Trial Name: NCT01590290 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What risks are associated with the pay for performance system?

"There is some data to support the efficacy of pay for performance, and multiple rounds of data have shown that it is a safe practise. Therefore, it received a score of 3."

Answered by AI

Are we looking for more participants in this experiment?

"The clinical trial in question is not recruiting patients at this time, however, according to the most recent information available on clinicaltrials.gov, this could change in the future. This study was first posted on 4/1/2012 and was last edited on 5/1/2012. Out of the 1,072 other trials recruiting patients, this one may start again soon."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
University of Virginia
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby Apr 2025